NasdaqCM - Nasdaq Real Time Price USD

Forian Inc. (FORA)

2.0600
+0.0400
+(1.98%)
As of 9:30:00 AM EDT. Market Open.
Loading Chart for FORA
  • Previous Close 2.0200
  • Open 2.0600
  • Bid 1.4400 x 200
  • Ask 2.7700 x 200
  • Day's Range 2.0600 - 2.0600
  • 52 Week Range 1.8500 - 4.0300
  • Volume 1,431
  • Avg. Volume 30,113
  • Market Cap (intraday) 64.259M
  • Beta (5Y Monthly) 1.04
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1200
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.00

Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company's subscription and services-based solutions cover the life sciences, pharmaceutical services, healthcare payer, and provider and financial services industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.

forian.com

47

Full Time Employees

December 31

Fiscal Year Ends

Recent News: FORA

View More

Performance Overview: FORA

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

FORA
0.00%
S&P 500 (^GSPC)
7.28%

1-Year Return

FORA
21.22%
S&P 500 (^GSPC)
8.29%

3-Year Return

FORA
39.41%
S&P 500 (^GSPC)
31.98%

5-Year Return

FORA
85.89%
S&P 500 (^GSPC)
87.24%

Compare To: FORA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FORA

View More

Valuation Measures

Annual
As of 4/29/2025
  • Market Cap

    67.38M

  • Enterprise Value

    39.02M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.33

  • Price/Book (mrq)

    2.24

  • Enterprise Value/Revenue

    1.94

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -18.71%

  • Return on Assets (ttm)

    -7.34%

  • Return on Equity (ttm)

    -13.05%

  • Revenue (ttm)

    20.15M

  • Net Income Avi to Common (ttm)

    -3.77M

  • Diluted EPS (ttm)

    -0.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    35.08M

  • Total Debt/Equity (mrq)

    22.40%

  • Levered Free Cash Flow (ttm)

    6.39M

Research Analysis: FORA

View More

Company Insights: FORA

Research Reports: FORA

View More

People Also Watch